Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 1/2010

01-01-2010 | 2009 SSAT Plenary Presentation

Detection of Free Peritoneal Cancer Cells in Gastric Cancer Using Cancer-Specific Newcastle Disease Virus

Authors: Joyce Wong, Allison Schulman, Kaitlyn Kelly, Dmitriy Zamarin, Peter Palese, Yuman Fong

Published in: Journal of Gastrointestinal Surgery | Issue 1/2010

Login to get access

Abstract

Introduction

Cytologic detection of peritoneal gastric cancer cells by Papanicolaou staining offers important prognostic information but has low sensitivity. We evaluated a novel detection technique using Newcastle disease virus expressing the enhanced green fluorescent protein (NDV-GFP) gene.

Methods

NDV-GFP was tested on MKN-1 human gastric adenocarcinoma cells plated upon rat hepatocytes to determine tumor-specific infection and GFP expression. Malignant ascites infected with increasing doses of virus was evaluated for NDV-GFP dose determination. Peritoneal lavage samples from 30 patients with gastric adenocarcinoma undergoing staging laparoscopy were evaluated with NDV-GFP.

Results

NDV-GFP can specifically detect one MKN-1 cell among one million benign rat hepatocytes. NDV-GFP at 5 × 106 plaque-forming units (PFU) produced optimal GFP expression in malignant ascites. Noncancerous cells were non-GFP expressing. GFP-expressing cells counterstained positive for carcinoembryonic antigen expression, confirming their cancerous origin. Furthermore, in patients with advanced gastric cancer, GFP expression was markedly enhanced over cytology. Of six patients with M1 disease discovered during laparoscopy, only 50% were cytology positive. All six, however, were NDV-GFP positive. Cytology was positive in 9% of patients with T3 disease, 8% with N1 disease, and 50% with N2 disease. In contrast, NDV-GFP was positive in 95% of T3 patients and 100% of patients with N1 or N2 disease.

Conclusions

NDV-GFP can specifically infect and detect peritoneal gastric cancer cells and offers a more sensitive method compared with conventional cytology. This novel modality may offer enhanced detection of intraperitoneal cancer spread and provide important prognostic information.
Literature
2.
go back to reference Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58(2):71–96.CrossRefPubMed Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58(2):71–96.CrossRefPubMed
3.
go back to reference Kwee RM, Kwee TC. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol 2007;25(15):2107–2116.CrossRefPubMed Kwee RM, Kwee TC. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol 2007;25(15):2107–2116.CrossRefPubMed
4.
go back to reference Blackshaw G, Lewis WG, Hopper AN, Morgan MA, Al-Khyatt W, Edwards P et al. Prospective comparison of endosonography, computed tomography, and histopathological stage of junctional oesophagogastric cancer. Clin Radiol 2008;63(10):1092–1098.CrossRefPubMed Blackshaw G, Lewis WG, Hopper AN, Morgan MA, Al-Khyatt W, Edwards P et al. Prospective comparison of endosonography, computed tomography, and histopathological stage of junctional oesophagogastric cancer. Clin Radiol 2008;63(10):1092–1098.CrossRefPubMed
5.
go back to reference Bentrem D, Wilton A, Mazumdar M, Brennan M, Coit D. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol 2005;12(5):347–353.CrossRefPubMed Bentrem D, Wilton A, Mazumdar M, Brennan M, Coit D. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol 2005;12(5):347–353.CrossRefPubMed
6.
go back to reference Badgwell B, Cormier JN, Krishnan S, Yao J, Staerkel GA, Lupo PJ et al. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol 2008;15(10):2684–2691.CrossRefPubMed Badgwell B, Cormier JN, Krishnan S, Yao J, Staerkel GA, Lupo PJ et al. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol 2008;15(10):2684–2691.CrossRefPubMed
7.
go back to reference Nath J, Moorthy K, Taniere P, Hallissey M, Alderson D. Peritoneal lavage cytology in patients with oesophagogastric adenocarcinoma. Br J Surg 2008;95(6):721–726.CrossRefPubMed Nath J, Moorthy K, Taniere P, Hallissey M, Alderson D. Peritoneal lavage cytology in patients with oesophagogastric adenocarcinoma. Br J Surg 2008;95(6):721–726.CrossRefPubMed
8.
go back to reference Yamaguchi K, Maeda S, Kitamura K. Papillary adenoma of the gallbladder associated with regurgitation of pancreatic juice through abnormally shaped union. Case report. Acta Chirurgica Scandinavica 1989;155(10):549–552.PubMed Yamaguchi K, Maeda S, Kitamura K. Papillary adenoma of the gallbladder associated with regurgitation of pancreatic juice through abnormally shaped union. Case report. Acta Chirurgica Scandinavica 1989;155(10):549–552.PubMed
9.
go back to reference Wilkiemeyer MB, Bieligk SC, Ashfaq R, Jones DB, Rege RV, Fleming JB. Laparoscopy alone is superior to peritoneal cytology in staging gastric and esophageal carcinoma. Surg Endosc 2004;18(5):852–856.CrossRefPubMed Wilkiemeyer MB, Bieligk SC, Ashfaq R, Jones DB, Rege RV, Fleming JB. Laparoscopy alone is superior to peritoneal cytology in staging gastric and esophageal carcinoma. Surg Endosc 2004;18(5):852–856.CrossRefPubMed
11.
go back to reference Batliwalla FM, Bateman BA, Serrano D, Murray D, Macphail S, Maino VC et al. A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire. Mol Med 1998;4(12):783–794.PubMed Batliwalla FM, Bateman BA, Serrano D, Murray D, Macphail S, Maino VC et al. A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire. Mol Med 1998;4(12):783–794.PubMed
12.
go back to reference Pecora AL, Rizvi N, Cohen GI, Meropol NJ, Sterman D, Marshall JL et al. Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers. J Clin Oncol 2002;20(9):2251–2266.CrossRefPubMed Pecora AL, Rizvi N, Cohen GI, Meropol NJ, Sterman D, Marshall JL et al. Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers. J Clin Oncol 2002;20(9):2251–2266.CrossRefPubMed
13.
go back to reference Romer-Oberdorfer A, Mundt E, Mebatsion T, Buchholz UJ, Mettenleiter TC. Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol 1999;80(Pt 11):2987–2995.PubMed Romer-Oberdorfer A, Mundt E, Mebatsion T, Buchholz UJ, Mettenleiter TC. Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol 1999;80(Pt 11):2987–2995.PubMed
14.
go back to reference Gao Q, Park MS, Palese P. Expression of transgenes from Newcastle disease virus with a segmented genome. J Virol 2008;82(6):2692–2698.CrossRefPubMed Gao Q, Park MS, Palese P. Expression of transgenes from Newcastle disease virus with a segmented genome. J Virol 2008;82(6):2692–2698.CrossRefPubMed
15.
go back to reference Nakaya T, Cros J, Park MS, Nakaya Y, Zheng H, Sagrera A et al. Recombinant Newcastle disease virus as a vaccine vector. J Virol 2001;75(23):11868–11873.CrossRefPubMed Nakaya T, Cros J, Park MS, Nakaya Y, Zheng H, Sagrera A et al. Recombinant Newcastle disease virus as a vaccine vector. J Virol 2001;75(23):11868–11873.CrossRefPubMed
16.
go back to reference Vigil A, Park MS, Martinez O, Chua MA, Xiao S, Cros JF et al. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Res 2007;67(17):8285–8292.CrossRefPubMed Vigil A, Park MS, Martinez O, Chua MA, Xiao S, Cros JF et al. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Res 2007;67(17):8285–8292.CrossRefPubMed
17.
go back to reference Wilke HJ, Van CE. Current treatments and future perspectives in colorectal and gastric cancer. Ann Oncol 2003;14(Suppl 2):ii49–ii55.PubMed Wilke HJ, Van CE. Current treatments and future perspectives in colorectal and gastric cancer. Ann Oncol 2003;14(Suppl 2):ii49–ii55.PubMed
18.
go back to reference Lambert J. Value of a dietary milk for infants in tube feeding. Sem Hop 1969;45(27):1908–1911.PubMed Lambert J. Value of a dietary milk for infants in tube feeding. Sem Hop 1969;45(27):1908–1911.PubMed
Metadata
Title
Detection of Free Peritoneal Cancer Cells in Gastric Cancer Using Cancer-Specific Newcastle Disease Virus
Authors
Joyce Wong
Allison Schulman
Kaitlyn Kelly
Dmitriy Zamarin
Peter Palese
Yuman Fong
Publication date
01-01-2010
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 1/2010
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-009-1071-8

Other articles of this Issue 1/2010

Journal of Gastrointestinal Surgery 1/2010 Go to the issue